Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio, Dotmatics Tap Japanese Distributors

Premium

CLC Bio and Dotmatics both announced this week that they have signed agreements with distributors for the Japanese market.

CLC Bio, based in Aarhus, Denmark, said that Filgen, a Nagoya, Japan-based provider of bioscience and nanoscience products, will resell its software for next-generation sequence analysis.

In addition, the firm has appointed David Leangen as CEO of CLC Bio Japan (see people in the news, this issue).

Michael Heltzen, director of partner sales at CLC Bio, said in a statement that the company has seen "a considerable increase of interest" this year from Japan for its next-generation sequencing software.

Dotmatics, meantime, a cheminformatics firm based in Bishop's Stortford, UK, has partnered with Tokyo-based Infocom.

As part of the agreement, Dotmatics and Infocom are working together to provide "dynamic query and visualization solutions" for pharmaceutical companies in Japan, Dotmatics said.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.